tirzepatide suomi Cipla launches Yurpeak® (tirzepatide), a one-weekly injectable therapy for managing obesity and type 2 diabetes mellitus (T2DM) — two of the country's most pressing health challenges. Cipla has the rights to distribute Tirzepatide: Injection Home Kit –

Another study published in 2025 looked at a clinical trial from the FDA

Rada P, Rojo AI, Evrard-Todeschi N, Innamorato NG, Cotte A, Jaworski T, et al

All referenced brand names and trademarks (Ozempic, Wegovy, Mounjaro, Zepbound, Dexcom Stelo, Dexcom G7) are the property of their respective owners

Water, Niacinamide, Dipropylene Glycol, Glycerin, Propanediol, Butylene Glycol, Hydroxyethyl Urea, Diethoxyethyl Succinate, Hydroxyacetophenone, Caprylyl Glycol, Polyglyceryl-10 Laurate, Betaine, Citric Acid, Panthenol, Ethylhexylglycerin, Gluconolactone, Sodium Polyacrylate, Disodium EDTA, Ammonium Acryloyldimethyltaurate/VP Copolymer, Sodium Citrate, Maltodextrin, 1,2-Hexanediol, Gardenia Florida Fruit Extract, Dipotassium Glycyrrhizate, Sodium Hyaluronate, Ascorbic Acid, Pantolactone, Tocopherol, Capryloyl Salicylic Acid, Tranexamic Acid, Tremella Fuciformis (Mushroom) Extract, Caprylic/Capric Triglyceride, Ascorbyl Glucoside, Ubiquinone, Hydrogenated Lecithin, Magnesium Chloride, Alcohol, Glutathione, Polysorbate 80, Calcium Gluconate, Pyridoxine HCl, BHT, Yeast Extract, Cyanocobalamin

doi: 10.1007/s00216-020-02612-w

BeShiny is committed to bringing you the highest quality, most effective, and scientifically advanced products for your skincare needs